Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03193476 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry for Patients With X-Linked Hypophosphatemia

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 1343 to 1489
    • Site details revised at 10 of 118 sites
    • Publications: 2 to 6
    v12
  2. Trial status: Active, Not Recruiting to Recruiting
    • Enrollment target: 1236 to 1343
    • Study sites: 112 to 118
    • Collaborators expanded, about 3 words
    v11
  3. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 1200 to confirmed 1236
    • Study sites: 116 to 112
    v10
  4. Start date: Sep 1, 2017 to Sep 12, 2017v9
  5. Re-verified, no change to tracked fieldsv8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 113 to 116v7
  2. Eligibility criteria expanded, about 6 words
    • Site details revised at 5 of 113 sites
    • Study description expanded, about 5 words
    v6
  3. Study sites: 106 to 113v5
  4. Study sites: 1 to 106
    • Study description expanded, about 18 words
    v4
  5. Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
    • Primary completion date: Sep 1, 2022 to Feb 1, 2029
    • Study sites: 0 to 1
    • Study completion date: Dec 1, 2022 to Jul 1, 2029
    • Eligibility criteria expanded, about 65 words
    • Study description expanded, about 131 words
  6. Primary completion date: Sep 1, 2027 to Sep 1, 2022v2 Show 4 more changesShow less
    • Primary endpoint revised
    • Study completion date: Dec 1, 2027 to Dec 1, 2022
    • Eligibility criteria shortened, about 6 words
    • Study description shortened, about 32 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an international, multicentre, prospective, non-interventional, observational Registry of patients with X-Linked hypophosphatemia (XLH). The main objective of this XLH Registry is to collect data to characterise the treatment, progression and long-term outcomes of XLH in both adult and paediatric settings.
Trial Details
NCT Number NCT03193476
Lead Sponsor Kyowa Kirin Pharmaceutical Development Ltd
Collaborators: IQVIA Pty Ltd
Conditions
(from sponsor)		 X-Linked Hypophosphatemia
Related terms Familial Hypophosphatemic Rickets
Enrollment 1,489 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov